-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
PharmaCyte Biotech, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2012 to 2023.
- PharmaCyte Biotech, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending July 31, 2024 was 7.87M shares, a 37.6% decline year-over-year.
- PharmaCyte Biotech, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 9.58M shares, a 50.8% decline from 2022.
- PharmaCyte Biotech, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 19.5M shares, a 25.6% increase from 2021.
- PharmaCyte Biotech, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 15.5M shares, a 972% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)